Dr. Richard S Siegel
Claim this profileIllinois Cancer Specialists
Studies Colorectal Cancer
Studies Tumors
8 reported clinical trials
18 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
MSI-H positive
dMMR positive
2Tumors
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Richard S Siegel is currently running
Botensilimab + Chemotherapy
for Pancreatic Cancer
This trial is testing whether adding a new drug, botensilimab, to standard chemotherapy can better treat patients with advanced pancreatic cancer. The study will ensure the new drug is safe and determine the right dose. It will also compare the effectiveness of the new combination treatment to chemotherapy alone.
Recruiting1 award Phase 2
TSR-022
for Cancer
This trial is testing TSR-022, a new medicine that helps the immune system fight cancer by blocking a protein called TIM-3. TIM-3 has gained prominence as a potential candidate for cancer immunotherapy, where it has been shown that blocking TIM-3 with other treatments enhances the body's ability to fight tumors and suppress their growth. It targets patients with tumors, especially those who may not respond to standard treatments. The goal is to see if this medicine can help the immune system better attack cancer cells.
Recruiting1 award Phase 1
More about Richard S Siegel
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Richard S Siegel has experience with
- Gemcitabine
- TSR-022
- Nivolumab
- Ipilimumab
- Fluorouracil
- Oxaliplatin
Breakdown of trials Richard S Siegel has run
Colorectal Cancer
Microsatellite Instability
Adenocarcinoma
Pancreatic Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard S Siegel specialize in?
Richard S Siegel focuses on Colorectal Cancer and Tumors. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are MSI-H positive.
Is Richard S Siegel currently recruiting for clinical trials?
Yes, Richard S Siegel is currently recruiting for 4 clinical trials in Arlington Heights Illinois. If you're interested in participating, you should apply.
Are there any treatments that Richard S Siegel has studied deeply?
Yes, Richard S Siegel has studied treatments such as Gemcitabine, TSR-022, Nivolumab.
What is the best way to schedule an appointment with Richard S Siegel?
Apply for one of the trials that Richard S Siegel is conducting.
What is the office address of Richard S Siegel?
The office of Richard S Siegel is located at: Illinois Cancer Specialists, Arlington Heights, Illinois 60005 United States. This is the address for their practice at the Illinois Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.